Jennifer Yvette Magness, PHARMD
Student in An Organized Health Care Education/Training Program · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jennifer Yvette Magness’s office at (408) 851-1000 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$98,416
Pharmacies billed $98,416 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 545) in 2024. At or below the middle of the specialty; the typical student in an organized health care education/training program clinician is at 0%.
287 generic and 210 brand-name prescriptions · $98,416 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 53 | $42,784 | $807 |
| Victoza 3-Pak | 11 | $9,088 | $826 |
| Humalog Kwikpen U-100 | 22 | $7,479 | $340 |
| Jardiance | 12 | $6,342 | $529 |
| Insulin Glargine-Yfgn | 39 | $5,281 | $135 |
See all 16 drugs
| Ozempic | 53 | $42,784 | $807 |
| Victoza 3-Pak | 11 | $9,088 | $826 |
| Humalog Kwikpen U-100 | 22 | $7,479 | $340 |
| Jardiance | 12 | $6,342 | $529 |
| Insulin Glargine-Yfgn | 39 | $5,281 | $135 |
| Humulin N | 25 | $3,861 | $154 |
| Humulin R | 18 | $3,509 | $195 |
| Atorvastatin | 65 | $879 | $14 |
| Metformin | 55 | $705 | $13 |
| Glipizide | 49 | $590 | $12 |
| Ultra-Fine Nano Pen Needle | 11 | $338 | $31 |
| Glipizide Er | 13 | $329 | $25 |
| Metformin Hcl Er | 22 | $202 | $9 |
| Lisinopril-Hydrochlorothiazide | 12 | $200 | $17 |
| Simvastatin | 15 | $175 | $12 |
| Pioglitazone | 11 | $148 | $13 |
Year by year
| 2024 | 545 | 176 | 0% (0) | 39% | $98,416 |
| 2023 | 548 | 115 | 0% (0) | 39% | $117,482 |
| 2022 | 100 | 60 | 0% (0) | 31% | $15,578 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Ozempic | 38 | $37,977 | $999 |
| Humalog Kwikpen U-100 | 18 | $6,732 | $374 |
| Humulin N | 38 | $6,219 | $164 |
| Humulin N Kwikpen | 14 | $4,277 | $305 |
| Humulin R | 25 | $4,076 | $163 |
| Lantus | 16 | $4,042 | $253 |
| Insulin Glargine-Yfgn | 17 | $2,343 | $138 |
| Glipizide | 61 | $796 | $13 |
| Metformin | 60 | $769 | $13 |
| Atorvastatin | 49 | $739 | $15 |
| Ultra-Fine Nano Pen Needle | 19 | $384 | $20 |
| Metformin Hcl Er | 36 | $353 | $10 |
| Veo Insulin | 12 | $294 | $24 |
2022: 1 drug
| Metformin Hcl Er | 11 | $100 | $9 |
Professional record
- NPI
- 1154095156
More record details
- Sole proprietor
- Yes
- Taxonomy
- Student in a training program (390200000X)
- Mailing address
- 887 Sakura Dr, San Jose, CA, 95112
- NPI first listed
- 2021-08-03
- NPI last updated
- 2021-08-03
- NPI record certified
- 2021-08-03
This is when the NPI record was last certified, not a medical board exam.